| Volume 5,Issue 2,2019 Table of Contents
论著 | | | Comparison of intra-pleural injection efficac?between Endostar and Bevacizumab combined with pemetrexed/cisplatin for the treatment of malignant pleural effusion in patients with ?epidermal growth factor receptor-/anaplastic lymphoma kinase-lung adenocarcinoma | | Yi Chen,Nan Huang,Kai Qin,Jing Zhao,Huihua Xiong,Shiying Yu,Tingting Huang and QiuYun Guo | | 2019,5(2):53-57 [Abstract] [View PDF] | | | | MyD88 exacerbates immunological pathology in experimental viral fulminant hepatitis* | | Jianzhao Deng,Qin Ning,Weiming Yan,Xuan Yang,Lizhen Zhao,Yuzhang Wu and Bei Zhang | | 2019,5(2):58-67 [Abstract] [View PDF] | | | | Prognostic significance of PD-L1 expression in patients with colorectal cancer: a meta-analysis | | Siwen Liu,Rong Ma,Haixia Cao,Dan Chen,Changwen Jing,Zhuo Wang,Junying Zhang,Yang Wu,Jifeng Feng and Jianzhong Wu | | 2019,5(2):68-74 [Abstract] [View PDF] | | | | Clinical significance of BRAFV600E and TERT promoter mutation in papillary thyroid microcarcinoma | | Jincai xue,qinjiang liu,youxin tian and xiaofeng hou | | 2019,5(2):75-79 [Abstract] [View PDF] | | | | Safety and efficacy of EFGR and VEGF signaling pathway inhibition therapy in patients with colorectal cancer: a meta-analysis | | Siwen Liu, Rong Ma, Haixia Cao, Shaorong Yu, Dan Chen, Changwen Jing, Zhuo Wang, Junying Zhang, Jifeng Feng and Jianzhong Wu | | 2019,5(2):80-90 [Abstract] [View PDF] | | | | Investigation of therapeutic modalities of G719X, ?an uncommon mutation in the EGFR gene ?in non-small cell lung cancer | | Hua Zheng,Yuan Gao,Zan Liu,Zhe Qian,Tongmei Zhang,Jie Li,Hongmei Zhang,Qunhui Wang,Fanbin Hu and Baolan Li | | 2019,5(2):91-97 [Abstract] [View PDF] | | |
病例报道
|